Vinay Prasad, CBER director (FDA via YouTube)
July 15, 2025 01:50 PM EDT
Pharma
FDA+
Coronavirus

Prasad again over­rode FDA vac­cine re­view­ers, this time on Mod­er­na’s Covid shot for young kids

Max Bayer

Pharma Reporter

The FDA’s vac­cines and bi­o­log­ics chief Vinay Prasad over­rode the agency’s vac­cine re­view­ers for a third time in re­cent weeks, when he nar­rowed the ap­proval …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mer­ck­'s PD-1xVEGF part­ner LaNo­va gets snapped up for $951M

FDA ques­tions safe­ty, ef­fi­ca­cy of GSK's Blenrep in mul­ti­ple myelo­ma ahead of ad­comm

The Trump ad­min­is­tra­tion dis­band­ed a new­born screen­ing pan­el. Ad­vo­cates now face a hard­er path

BMS warns against ‘in­dis­crim­i­nate use’ of rene­go­ti­a­tions as CMS plans next drug price talks

Up­dat­ed: Af­ter Phase 3 obe­si­ty suc­cess, Hen­grui plans Chi­na ap­proval fil­ing for Kail­era-part­nered drug

About 2.5% of all drug patents cite gov­ern­ment fund­ing, new study finds

A service from the Financial Times